Insights in febrile neutropenia (SAFE study) and clinical and translational insights in (invasive) mold infections and mycology, with the focus on Hematologic patients. KU Leuven
In this thesis, there is both a clinical and translational hatch. Concerning the clinical part, the thesis will focus on the SAFE study (Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS), a multicentre prospective study, which will investigate whether it is safe to stop broad-spectrum antibiotics after 72 h in neutropenic fever (under the right conditions) with a possible ...